Examples of 'been studied in patients' in a sentence
Meaning of "been studied in patients"
been studied in patients ~ refers to a specific subject or topic that has been researched or analyzed within a group of individuals receiving medical treatment
How to use "been studied in patients" in a sentence
Basic
Advanced
been studied in patients
Tivicay has not been studied in patients on dialysis.
Efficacy and safety of sevelamer hydrochloride has not been studied in patients with.
Juluca has not been studied in patients on dialysis.
The safety and efficacy of BindRen has not been studied in patients with.
Has not been studied in patients with a history of pancreatitis.
Rilpivirine has not been studied in patients.
NovoSeven has been studied in patients with haemophilia and in patients with factor VII deficiency.
Tipranavir pharmacokinetics have not been studied in patients with renal impairment.
It has not been studied in patients with pre-existing low leukocyte or lymphocyte counts.
The pharmacokinetics of omalizumab have been studied in patients with allergic asthma.
Valsartan has been studied in patients with post myocardial infarction and heart failure.
The pharmacokinetics of palbociclib have not been studied in patients requiring haemodialysis.
Possia has not been studied in patients with moderate or severe hepatic impairment.
The pharmacokinetics of deferasirox have not been studied in patients with renal impairment.
Yellox has not been studied in patients with hepatic disease or renal impairment.
The pharmacokinetics of emtricitabine has not been studied in patients with hepatic impairment.
Vandetanib has not been studied in patients with ventricular arrhythmias or recent myocardial infarction.
The pharmacokinetics of emtricitabine have not been studied in patients with hepatic impairment.
Lucentis has not been studied in patients who have previously received intravitreal injections.
The pharmacokinetics of enfuvirtide have not been studied in patients with hepatic impairment.
Nerlynx has not been studied in patients with severe renal impairment including patients on dialysis.
The pharmacokinetics of rilpivirine have not been studied in patients with renal insufficiency.
Exenatide has not been studied in patients with severe gastrointestinal disease, including gastroparesis.
The pharmacokinetics of efavirenz have not been studied in patients with renal impairment.
SUTENT has not been studied in patients with severe kidney or severe liver problems.
Ritonavir pharmacokinetic parameters have not been studied in patients with renal impairment.
Idelalisib has not been studied in patients with chronic active hepatitis including viral hepatitis.
The pharmacokinetics of hydrochlorothiazide has not been studied in patients with cardiac failure.
Zinbryta has not been studied in patients with immunodeficiency syndromes.
The effect of citicoline on visual function has been studied in patients with glaucoma.
Numient has not been studied in patients with hepatic impairment.
The use of Elidel under occlusion has not been studied in patients.
Temsirolimus has not been studied in patients undergoing haemodialysis.
The use of Protopic ointment under occlusion has not been studied in patients.
Natpar has not been studied in patients with urolithiasis.
The use of Protopy ointment under occlusion has not been studied in patients.
Rimonabant has not been studied in patients being treated for epilepsy.
The single and multiple dose pharmacokinetics of lanadelumab have been studied in patients with HAE.
Busulfan has not been studied in patients with hepatic impairment.
Agenerase capsules ( without the boosting effect of ritonavir ) have been studied in patients with.
Zavesca has not been studied in patients with liver problems.
Efficacy and safety of Renagel has not been studied in patients with,.
Cerdelga has not been studied in patients with hepatic impairment.
Renal impairment, the pharmacokinetics of maraviroc have not been studied in patients with renal impairment.
Thiotepa has not been studied in patients with hepatic impairment.
Hepatic impairment, The pharmacokinetics of enfuvirtide have not been studied in patients with hepatic impairment.
Cerdelga has not been studied in patients with renal impairment.
Pharmacokinetics of abatacept for subcutaneous injection have been studied in patients 2 to 17 years of age.
Visudyne has not been studied in patients with renal impairment.
The use of < Invented Name > under occlusion has not been studied in patients.
You'll also be interested in:
Examples of using Patients
Show more
Patients at the very heart of our mission
We have the best patients in the world
Patients also pay for essential drugs
Examples of using Studied
Show more
This subject is studied for five years
Studied all about you quiet guys
It has not been studied in these age groups
